The Delta variant was first identified in the United States in April and by May it was well onto its exponential growth curve, doubling every 10-12 days, as the basis for Covid infections, now reaching over 96% prevalence. Ironically, on 1 May, the CDC announced it would stop monitoring post-vaccination breakthrough infections unless they led to hospitalizations or deaths. This decision can be seen as exceptionally ill-advised and has led to a country flying blind in its attempt to confront its fourth wave of infections – one that has rapidly led to well over 100,000 new cases per day and more than 60,000 hospitalizations, both higher than the US first and second pandemic waves. It is unfathomable that we do not know how many of these are occurring in people who were vaccinated.
Most people who get Covid infections after being fully vaccinated have mild to moderate symptoms, and generally have been thought to avoid hospitalizations. But that sense of confidence about vaccine protection was built upon the pre-Delta data when the CDC was monitoring breakthroughs. Still being reported by CDC, from their latest website data, and a constant refrain from public health officials, is that “99.99% of people fully vaccinated against Covid-19 have not had a breakthrough case resulting in hospitalization or death.” That could not be further from the truth. In the July Provincetown Delta outbreaks that the CDC reported on the risk of fully vaccinated requiring hospitalization was 1%, not .01%, and that may not be a reliable estimate for the incidence of such infections occurring throughout the country.
Why is this so critically important? For one, the false sense of security transmitted by CDC’s lack of data in the Delta wave likely fosters complacency and lack of protective measures such as masks and distancing. The mission of the CDC to prevent such illness, and the first step is to collect the relevant data. It would be very simple to know the vaccination status of every American with a breakthrough infection admitted to the hospital with Covid-19, along with key demographics such as age, time from vaccination, which vaccine, and co-existing medical conditions. The PCR diagnostic test for each patient has an accompanying cycle threshold (Ct) value, which is an indicator of viral load, and would be important to track. Moreover, the sample of the virus could undergo genomic sequencing to determine whether there has been further evolution of the virus and blood samples for neutralizing antibody levels that could be obtained in as many patients as possible. Contact tracing of these individuals would help determine the true rate of transmission from other vaccines, something that is pure conjecture. Such systematic collection of data would be the foundation for understanding who is at risk for breakthrough infections, determining the current level of effectiveness of vaccines and whether, when, and in whom, booster shots should be recommended. It is remarkable that none of this is getting done for hospitalized patients, who represent an undetermined fraction of the people who are getting quite ill, some requiring monoclonal antibody infusions to pre-empt getting admitted.
This is not by any means the first breakdown of the CDC in managing and communicating about the pandemic. But with billions of dollars allocated to CDC earlier this year for improved Covid-19 surveillance, this represents a blatant failure that is putting millions of vaccinated Americans at unnecessary risk for breakthrough infections and leaving us without a navigational system for the US Delta wave.
News
Platelet-inspired nanoparticles could improve treatment of inflammatory diseases
Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness. Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly [...]
After 150 years, a new chapter in cancer therapy is finally beginning
For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, [...]
Older chemical libraries show promise for fighting resistant strains of COVID-19 virus
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego scientists and an international team of [...]
Lower doses of immunotherapy for skin cancer give better results, study suggests
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National [...]
Researchers highlight five pathways through which microplastics can harm the brain
Microplastics could be fueling neurodegenerative diseases like Alzheimer's and Parkinson's, with a new study highlighting five ways microplastics can trigger inflammation and damage in the brain. More than 57 million people live with dementia, [...]
Tiny Metal Nanodots Obliterate Cancer Cells While Largely Sparing Healthy Tissue
Scientists have developed tiny metal-oxide particles that push cancer cells past their stress limits while sparing healthy tissue. An international team led by RMIT University has developed tiny particles called nanodots, crafted from a metallic compound, [...]
Gold Nanoclusters Could Supercharge Quantum Computers
Researchers found that gold “super atoms” can behave like the atoms in top-tier quantum systems—only far easier to scale. These tiny clusters can be customized at the molecular level, offering a powerful, tunable foundation [...]
A single shot of HPV vaccine may be enough to fight cervical cancer, study finds
WASHINGTON -- A single HPV vaccination appears just as effective as two doses at preventing the viral infection that causes cervical cancer, researchers reported Wednesday. HPV, or human papillomavirus, is very common and spread [...]
New technique overcomes technological barrier in 3D brain imaging
Scientists at the Swiss Light Source SLS have succeeded in mapping a piece of brain tissue in 3D at unprecedented resolution using X-rays, non-destructively. The breakthrough overcomes a long-standing technological barrier that had limited [...]
Scientists Uncover Hidden Blood Pattern in Long COVID
Researchers found persistent microclot and NET structures in Long COVID blood that may explain long-lasting symptoms. Researchers examining Long COVID have identified a structural connection between circulating microclots and neutrophil extracellular traps (NETs). The [...]
This Cellular Trick Helps Cancer Spread, but Could Also Stop It
Groups of normal cbiells can sense far into their surroundings, helping explain cancer cell migration. Understanding this ability could lead to new ways to limit tumor spread. The tale of the princess and the [...]
New mRNA therapy targets drug-resistant pneumonia
Bacteria that multiply on surfaces are a major headache in health care when they gain a foothold on, for example, implants or in catheters. Researchers at Chalmers University of Technology in Sweden have found [...]
Current Heart Health Guidelines Are Failing To Catch a Deadly Genetic Killer
New research reveals that standard screening misses most people with a common inherited cholesterol disorder. A Mayo Clinic study reports that current genetic screening guidelines overlook most people who have familial hypercholesterolemia, an inherited disorder that [...]
Scientists Identify the Evolutionary “Purpose” of Consciousness
Summary: Researchers at Ruhr University Bochum explore why consciousness evolved and why different species developed it in distinct ways. By comparing humans with birds, they show that complex awareness may arise through different neural architectures yet [...]
Novel mRNA therapy curbs antibiotic-resistant infections in preclinical lung models
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria. The findings, published in Nature Biotechnology, show that in [...]
New skin-permeable polymer delivers insulin without needles
A breakthrough zwitterionic polymer slips through the skin’s toughest barriers, carrying insulin deep into tissue and normalizing blood sugar, offering patients a painless alternative to daily injections. A recent study published in the journal Nature examines [...]















